Hostname: page-component-7b7567c8c-z4zkx Total loading time: 0 Render date: 2026-11-19T03:08:36.387Z Has data issue: false hasContentIssue false

Disulfiram Implant: A Controlled Trial

Published online by Cambridge University Press:  29 January 2018

C. R. Whyte
Affiliation:
Lynfield Mount Hospital, Bradford 9, Yorkshire
P. M. J. O'Brien
Affiliation:
Scalebor Park Hospital, Burley-in-Wharfedale, Yorkshire
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

Hald and Jacobsen (1948) introduced disulfiram as an adjunct in the treatment of alcoholism. Its usefulness has, however, been limited by the ease with which patients may discontinue medication and resume drinking. A preparation of disulfiram suitable for implantation was developed some years ago, and though its use has been mainly confined to the continent of Europe, several case reports have been published in this country (Kellam et al., 1968; Kellam, 1969). Madden and Malcolm (1972) suggest, from a follow-up study of 47 alcoholics, that implantation is followed by a period of sobriety of about six months, but they have made no comparison with a control group of patients.

Information

Type
Research Article
Copyright
Copyright © Royal College of Psychiatrists, 1974 

This journal is not currently accepting new eletters.

eLetters

No eLetters have been published for this article.